Atezolizumab for first-line treatment of metastatic non-squamous NSCLC

IMpower150 Study Group, Michael Millward

Research output: Contribution to journalArticlepeer-review

1428 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Atezolizumab for first-line treatment of metastatic non-squamous NSCLC'. Together they form a unique fingerprint.

Medicine & Life Sciences